Brick & Kyle Associates’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Brick & Kyle Associates’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-755	Closed	–	–	455
2016 Q3	$0	Hold	755	–	–	﹤0.01%	459
2016 Q2	$0	Hold	755	–	–	﹤0.01%	459
2016 Q1	$1K	Hold	755	–	–	﹤0.01%	427
2015 Q4	$1K	Hold	755	–	–	﹤0.01%	417
2015 Q3	$1K	Hold	755	–	–	﹤0.01%	424
2015 Q2	$1K	Hold	755	–	–	﹤0.01%	447
2015 Q1	$1K	Hold	755	–	–	﹤0.01%	449
2014 Q4	$1K	Buy	+755	New	+$1K	﹤0.01%	434

Brick & Kyle Associates's RXII Position: Q4 2016 in Review

Brick & Kyle Associates sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 755 shares.

Brick & Kyle Associates first reported a position in RXII in Q4 2014 and held it in 8 quarters. The position peaked at $1K in Q1 2016. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Brick & Kyle Associates reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Brick & Kyle Associates sold 755 GALENA BIOPHARMA INC COM shares in Q4 2016.
Brick & Kyle Associates first reported a position in GALENA BIOPHARMA INC COM in Q4 2014 and held it in 8 quarters.
Brick & Kyle Associates's GALENA BIOPHARMA INC COM position peaked at $1K in Q1 2016.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Brick & Kyle Associates's 13F filing for Q4 2016, filed 5 Jan 2017.